Home » Authors » Cormac Sheridan

Cormac Sheridan

Articles

ARTICLES

Actelion Looks To Open Up Secondary Markets For Tracleer

Aug. 21, 2002

By Cormac Sheridan

Cureon Raises DKK34M For Antisense DNA Analogue

Aug. 14, 2002

By Cormac Sheridan

Cureon Raises DKK34M For Antisense DNA Analogue

Aug. 14, 2002

By Cormac Sheridan

Elan Selling Off Assets, Cutting Employees In Restructuring Plan

Aug. 7, 2002

By Cormac Sheridan

Elan Selling Off Assets, Cutting Employees In Restructuring Plan

Aug. 7, 2002

By Cormac Sheridan

Genmab Pulling Listing From Germany's Troubled Neuer Markt

July 31, 2002

By Cormac Sheridan

Genmab Pulling Listing From Germany's Troubled Neuer Markt

July 31, 2002

By Cormac Sheridan

Stem Cell Research Center To Push Science In Denmark

July 24, 2002

By Cormac Sheridan

Stem Cell Research Center To Push Science In Denmark

July 24, 2002

By Cormac Sheridan

Swiss Start-Up Addex Raises CHF15.75M To Treat Addiction

July 17, 2002

By Cormac Sheridan

View All Articles by Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...